175 related articles for article (PubMed ID: 31759270)
1. Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.
Parekh TM; Bhatia S; Cherrington A; Kim YI; Lambert A; Iyer A; Regan EA; DeMeo DL; Han M; Dransfield MT
Respir Med; 2020 Jan; 161():105820. PubMed ID: 31759270
[TBL] [Abstract][Full Text] [Related]
2. 10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study.
Ragland MF; Strand M; Baraghoshi D; Young KA; Kinney GL; Austin E; Hokanson JE; Regan E; Crapo J; Silverman EK; Make B
Ann Am Thorac Soc; 2022 Mar; 19(3):381-388. PubMed ID: 34461026
[No Abstract] [Full Text] [Related]
3. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
[TBL] [Abstract][Full Text] [Related]
4. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
5. Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease.
Koo HK; Hoth KF; Make BJ; Regan EA; Crapo JD; Silverman EK; DeMeo DL
Respir Res; 2022 Jan; 23(1):19. PubMed ID: 35093071
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.
Wan ES; Fortis S; Regan EA; Hokanson J; Han MK; Casaburi R; Make BJ; Crapo JD; DeMeo DL; Silverman EK;
Am J Respir Crit Care Med; 2018 Dec; 198(11):1397-1405. PubMed ID: 29874098
[TBL] [Abstract][Full Text] [Related]
7. Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.
Martinez CH; Okajima Y; Murray S; Washko GR; Martinez FJ; Silverman EK; Lee JH; Regan EA; Crapo JD; Curtis JL; Hatabu H; Han MK;
Respir Res; 2014 Jun; 15(1):62. PubMed ID: 24894541
[TBL] [Abstract][Full Text] [Related]
8. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Radiologic Disease in Smokers With Normal Spirometry.
Regan EA; Lynch DA; Curran-Everett D; Curtis JL; Austin JH; Grenier PA; Kauczor HU; Bailey WC; DeMeo DL; Casaburi RH; Friedman P; Van Beek EJ; Hokanson JE; Bowler RP; Beaty TH; Washko GR; Han MK; Kim V; Kim SS; Yagihashi K; Washington L; McEvoy CE; Tanner C; Mannino DM; Make BJ; Silverman EK; Crapo JD;
JAMA Intern Med; 2015 Sep; 175(9):1539-49. PubMed ID: 26098755
[TBL] [Abstract][Full Text] [Related]
10. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
[TBL] [Abstract][Full Text] [Related]
11. Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry.
Fortis S; Wan ES; Kunisaki K; Eyck PT; Ballas ZK; Bowler RP; Crapo JD; Hokanson JE; Wendt C; Silverman EK; Comellas AP
Respir Med X; 2021 Nov; 3():. PubMed ID: 35911870
[TBL] [Abstract][Full Text] [Related]
12. Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
Labaki WW; Gu T; Murray S; Curtis JL; Wells JM; Bhatt SP; Bon J; Diaz AA; Hersh CP; Wan ES; Kim V; Beaty TH; Hokanson JE; Bowler RP; Arenberg DA; Kazerooni EA; Martinez FJ; Silverman EK; Crapo JD; Make BJ; Regan EA; Han MK; ;
Am J Respir Crit Care Med; 2023 Aug; 208(4):451-460. PubMed ID: 37159910
[No Abstract] [Full Text] [Related]
13. The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
Kim V; Zhao H; Regan E; Han MK; Make BJ; Crapo JD; Jones PW; Curtis JL; Silverman EK; Criner GJ;
Chest; 2019 Oct; 156(4):685-695. PubMed ID: 31047955
[TBL] [Abstract][Full Text] [Related]
14. Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study.
Yang HM; Ryu MH; Carey VJ; Kinney GL; Hokanson JE; Dransfield MT; Hersh CP; Silverman EK;
J Am Heart Assoc; 2024 Jun; 13(11):e033882. PubMed ID: 38818936
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
Fraser A; Poole P
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
[TBL] [Abstract][Full Text] [Related]
16. Associations Between Muscle Weakness and Clinical Outcomes in Current and Former Smokers.
Zou RH; Nouraie SM; Rossiter HB; McDonald ML; DeMeo DL; Mason S; Washko GR; Saha PK; Make BJ; Casaburi R; Regan EA; Bon J;
Chronic Obstr Pulm Dis; 2023 Jan; 10(1):112-121. PubMed ID: 36599111
[TBL] [Abstract][Full Text] [Related]
17. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
Camac ER; Voelker H; Criner GJ;
Respir Med; 2021 Sep; 186():106526. PubMed ID: 34229290
[TBL] [Abstract][Full Text] [Related]
18. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
Chaudhary MFA; Hoffman EA; Guo J; Comellas AP; Newell JD; Nagpal P; Fortis S; Christensen GE; Gerard SE; Pan Y; Wang D; Abtin F; Barjaktarevic IZ; Barr RG; Bhatt SP; Bodduluri S; Cooper CB; Gravens-Mueller L; Han MK; Kazerooni EA; Martinez FJ; Menchaca MG; Ortega VE; Iii RP; Schroeder JD; Woodruff PG; Reinhardt JM
Lancet Digit Health; 2023 Feb; 5(2):e83-e92. PubMed ID: 36707189
[TBL] [Abstract][Full Text] [Related]
19. Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers.
Bhatt SP; Terry NL; Nath H; Zach JA; Tschirren J; Bolding MS; Stinson DS; Wilson CG; Curran-Everett D; Lynch DA; Putcha N; Soler X; Wise RA; Washko GR; Hoffman EA; Foreman MG; Dransfield MT;
JAMA; 2016 Feb; 315(5):498-505. PubMed ID: 26836732
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
Busch R; Han MK; Bowler RP; Dransfield MT; Wells JM; Regan EA; Hersh CP;
BMC Pulm Med; 2016 Feb; 16():28. PubMed ID: 26861867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
